

Can't find Insulin Aspart (NovoLog) at your pharmacy? Here are proven tools and tips to locate it in stock near you in 2026.
If you've been told your pharmacy doesn't have Insulin Aspart in stock, don't panic. You're one of thousands of patients dealing with this same problem in 2026. With ongoing shortages affecting NovoLog and Fiasp products, finding your mealtime insulin can feel like a scavenger hunt.
But there are real, practical strategies that work. In this guide, we'll walk you through the best tools and tips to find Insulin Aspart in stock near you — starting with the fastest option.
The single most effective thing you can do is use Medfinder to check which pharmacies near you currently have Insulin Aspart in stock.
Here's how it works:
Medfinder pulls real-time data, so you're not wasting time calling pharmacies one by one. This is especially helpful during a shortage when availability can change day to day.
You can also read our detailed walkthrough on how to check if a pharmacy has Insulin Aspart in stock.
When a medication is in short supply, the big chain pharmacies — CVS, Walgreens, Rite Aid — tend to run out first. They serve the most patients and often have standardized ordering systems that make it harder to source scarce medications quickly.
Independent pharmacies are often your best bet during a shortage. Here's why:
To find independent pharmacies near you, search on Google Maps for "independent pharmacy" or "compounding pharmacy" in your area. You can also ask your doctor's office — they often know which local pharmacies are more reliable during shortages.
Specialty pharmacies that focus on diabetes supplies may also be worth contacting, as they sometimes maintain dedicated insulin inventory.
Pharmacies typically receive shipments from their wholesalers on specific days — often early in the week (Monday through Wednesday). If you can time your refill requests to align with delivery schedules, you'll have a better chance of getting your Insulin Aspart.
Here are a few timing strategies:
If you've tried the tips above and you're still coming up empty, here are additional steps to take:
Your prescriber may be able to switch you to another rapid-acting insulin like Insulin Lispro (Humalog) or Insulin Glulisine (Apidra). These work similarly to Insulin Aspart and may be more readily available. Read our full guide on alternatives to Insulin Aspart for more details.
Novo Nordisk's patient support program, NovoCare, can help locate supply and connect you with assistance programs. Call 1-888-668-6444 or visit novocare.com.
Mail-order pharmacies connected to your insurance plan may have access to different supply channels than retail pharmacies. Contact your insurance company to find out if mail-order is an option for your Insulin Aspart prescription.
If you can get a 90-day supply through mail order or a preferred pharmacy, you'll reduce the number of times you need to deal with availability issues. Talk to your doctor about writing a 90-day prescription.
Endocrinologists and primary care providers sometimes have insulin samples from pharmaceutical representatives. If you're in a bind, ask your doctor's office if they have any NovoLog or Fiasp samples that can bridge you until your pharmacy gets a shipment.
The best strategy is to be proactive rather than reactive. Here's a quick checklist:
Finding Insulin Aspart during a shortage takes some extra effort, but it's absolutely doable. Use technology like Medfinder, think beyond the big chain pharmacies, and stay in close contact with your healthcare team. Your diabetes management shouldn't be derailed by supply chain problems — and with the right approach, it won't be.
If cost is also a concern, check out our guide on how to save money on Insulin Aspart in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.